View Archive

Credit Designation

Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.5 contact hours (0.15 CEU) under the ACPE universal activity number 0290-0000-21-254-L01-P. The activity is available for CE credit through September 22, 2021.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Physicians’ Education Resource®, LLC, and Pharmacy Times Continuing Education™. Physicians’ Education Resource®, LLC is accredited by the ACCME to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians’ Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669, for 1.5 Contact Hours.

Acknowledgment of Commercial Support

This activity is supported by educational grants from Sandoz Inc., a Novartis Division, and Coherus BioSciences.

Discussing Clinical and Payer Insights to Encourage the Adoption of Oncology Biosimilars into Practice

Discussing Clinical and Payer Insights to Encourage the Adoption of Oncology Biosimilars into Practice

July 22, 2021

Live, Interactive Webcast!

8:00 PM – 9:30 PM EDT


The number of available biosimilars on the market for oncology-related indications continues to increase. The manufacturing and development process of biosimilars can be complex, and clinicians may be reluctant to modify prescribing practices or formularies because of these factors. Uncertainty about risks and benefits of oncology biosimilars and their use for either supportive care or treatment has been documented as a barrier to biosimilar uptake. Managed care professionals and pharmacists working with biosimilars need to maintain consistent messaging to both clinicians and patients about their use. The multidisciplinary discussion will cover topics such as extrapolation, interchangeability, and implementation challenges for preferred formulary agents that managed care professionals will encounter when incorporating biosimilars into clinical practice. The panelists will also present strategies and practice guidelines that can be employed to help guide the adoption and optimization of use of oncology biosimilars.

Acknowledgment of Commercial Support

This activity is supported by educational grants from Sandoz Inc., a Novartis Division, and Coherus BioSciences.

Target Audience

This activity is directed toward managed care and oncology pharmacists, medical oncologists, and nurses.

Instructions for Completing the Activity and Receiving CPE Credit

Pharmacists are requested to register for this program at: https://www.pharmacytimes.org/live/discussing-clinical-and-payer-insights-to-encourage-the-adoption-of-oncology-biosimilars-into-practice. To receive CPE credit, participants must complete the pretest, view the webcast in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.

Learning Objectives

Upon completion of this activity, participants will be able to:

  • Classify the core concepts that drive the biosimilar approval process and identify how it differs from the approval of an originator biologic.
  • Examine the available and emerging oncology biosimilars, their indications, and their originator biologics.
  • Identify clinical and nonclinical barriers that affect the implementation of oncology biosimilars in clinical practice.
  • Differentiate the roles of pharmacists, oncologists, and payers in developing strategies to implement oncology biosimilars in clinical practice.


2 Ways to Register
  1. Online: click here.
  2. Phone: Please call (888) 949-0045 or (609) 378-3701

Physicians' Education Resource®
2 Clarke Drive
Suite 110
Cranbury, NJ 08512
Registration Fee - Free

For registration assistance, please email info@gotoper.com, or call (888) 949-0045 or (609) 378-3701.

Physicians' Education Resource®, LLC (PER®) fully complies with the legal requirements of the ADA and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please notify us in order to receive service. Please call (609) 378-3701.

Physicians' Education Resource®, LLC reserves the exclusive rights to all recordings or reproductions of the conference and supporting materials. Unauthorized recording, by any means, is expressly prohibited.  This includes, but is not limited to, recording of presentations or reproductions of supporting audio/visual materials, exhibits, and other supporting Continuing Education materials.

By attending a PER® conference, meeting or related activity ("Events"), all participants, attendees, exhibitors, sponsors, and guests ("you") create an agreement between you and PER® regarding the use and distribution of your image, including but not limited to your name, voice, and likeness ("Image"). By attending the Events, you acknowledge and agree that photographs, video, and/or audio recordings may be taken of you and you grant permission to PER® (and its agents) to utilize, in perpetuity, your Image in any electronic or print distribution, or by other means hereinafter created, both now and in the future, for any lawful purpose as determined by PER®.

Meeting information is accurate at the time of posting.

PER® complies with the Physician Payments Sunshine Act as a part of the Affordable Care Act (ACA). Accordingly, we may be required to collect information on transfers of value provided to any covered recipient under the ACA.


You must be logged in to PER to register for this meeting

Or Register for PER now

*Required Fields

Login Information

Registration Information

Professional Information


Calendar of Events
Filter By